Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
20.14
+0.69 (3.55%)
At close: Nov 6, 2026, 4:00 PM EST
20.40
+0.26 (1.29%)
After-hours: Nov 6, 2026, 7:30 PM EST
Amneal Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 157.4 | 282.03 | 110.55 | 91.54 | 25.98 | 247.79 |
Short-Term Investments | - | 4.44 | 1.87 | 2.2 | 1.82 | 1.17 |
Cash & Short-Term Investments | 157.4 | 286.47 | 112.42 | 93.74 | 27.8 | 248.96 |
Cash Growth | -22.64% | 154.82% | 19.93% | 237.24% | -88.83% | -27.43% |
Accounts Receivable | 1,017 | 895.14 | 775.73 | 613.73 | 741.79 | 662.58 |
Other Receivables | 1.88 | 44.73 | 32.83 | 31.93 | 54.62 | 32.06 |
Receivables | 1,019 | 939.87 | 808.56 | 645.66 | 796.41 | 694.64 |
Inventory | 707.96 | 606.3 | 612.45 | 581.38 | 530.74 | 489.39 |
Prepaid Expenses | 196.77 | 49.7 | 46.5 | 49.51 | 47.13 | 45.07 |
Restricted Cash | 14.17 | 28.84 | 7.87 | 7.57 | 9.25 | 8.95 |
Other Current Assets | - | - | - | - | 0.5 | 33.1 |
Total Current Assets | 2,095 | 1,911 | 1,588 | 1,378 | 1,412 | 1,520 |
Property, Plant & Equipment | 725.67 | 550.33 | 523.69 | 550.14 | 589.36 | 639 |
Long-Term Investments | - | 5.76 | 35.92 | 37.09 | 85.59 | - |
Goodwill | - | 595.47 | 597.44 | 598.63 | 598.85 | 593.02 |
Other Intangible Assets | 2,324 | 563.5 | 732.38 | 890.42 | 1,096 | 1,167 |
Long-Term Deferred Charges | - | 5.2 | 2.82 | 4.43 | 2.21 | 1.6 |
Other Long-Term Assets | 122.81 | 46.85 | 21.39 | 14 | 15.43 | 19.01 |
Total Assets | 5,267 | 3,678 | 3,501 | 3,473 | 3,799 | 3,940 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 788.83 | 254.93 | 259.84 | 145.53 | 166.84 | 132.87 |
Accrued Expenses | - | 328.59 | 317.53 | 246.01 | 218.21 | 220.57 |
Short-Term Debt | 180 | - | 100 | 179 | 60 | - |
Current Portion of Long-Term Debt | 23.93 | 6.76 | 224.21 | 34.13 | 29.96 | 30.61 |
Current Portion of Leases | 21.63 | 14.82 | 16.04 | 14.5 | 14.68 | 15.42 |
Current Income Taxes Payable | - | - | - | - | - | 2.52 |
Other Current Liabilities | 105.45 | 276.54 | 212.14 | 227.43 | 263.11 | 275.24 |
Total Current Liabilities | 1,120 | 881.63 | 1,130 | 846.6 | 752.8 | 677.24 |
Long-Term Debt | 2,916 | 2,565 | 2,162 | 2,427 | 2,632 | 2,730 |
Long-Term Leases | 141.84 | 102.36 | 91.09 | 95.45 | 108.81 | 111.93 |
Other Long-Term Liabilities | 449.34 | 123.21 | 163.33 | 41.77 | 97.12 | 37.05 |
Total Liabilities | 4,627 | 3,672 | 3,546 | 3,411 | 3,590 | 3,556 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 531.26 | 3.15 | 3.1 | 3.07 | 3.04 | 3.01 |
Additional Paid-In Capital | - | 571.79 | 560.21 | 539.24 | 691.63 | 658.35 |
Retained Earnings | - | -535.01 | -607.06 | -490.18 | -406.18 | -276.2 |
Comprehensive Income & Other | - | -110.73 | -65.51 | -32.35 | 9.94 | -24.83 |
Total Common Equity | 531.26 | -70.79 | -109.27 | 19.78 | 298.42 | 360.34 |
Minority Interest | 109.45 | 76.76 | 64.73 | 41.52 | -89.49 | 23.54 |
Shareholders' Equity | 640.71 | 5.96 | -44.54 | 61.3 | 208.93 | 383.88 |
Total Liabilities & Equity | 5,267 | 3,678 | 3,501 | 3,473 | 3,799 | 3,940 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3,283 | 2,689 | 2,593 | 2,751 | 2,845 | 2,888 |
Net Cash (Debt) | -3,125 | -2,403 | -2,481 | -2,657 | -2,817 | -2,639 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -9.37 | -7.40 | -8.03 | -15.08 | -18.66 | -17.38 |
Filing Date Shares Outstanding | 335.73 | 314.63 | 309.97 | 307.01 | 151.5 | 149.42 |
Total Common Shares Outstanding | 335.73 | 314.57 | 309.88 | 306.57 | 151.49 | 149.41 |
Working Capital | 975.18 | 1,030 | 458.04 | 531.27 | 659.02 | 842.87 |
Book Value Per Share | 1.58 | -0.23 | -0.35 | 0.06 | 1.97 | 2.41 |
Tangible Book Value | -1,792 | -1,230 | -1,439 | -1,469 | -1,397 | -1,400 |
Tangible Book Value Per Share | -5.34 | -3.91 | -4.64 | -4.79 | -9.22 | -9.37 |
Land | - | 19.69 | 8.11 | 9.02 | 10.71 | 11.54 |
Buildings | - | 234.6 | 224.66 | 227.84 | 225.63 | 230.99 |
Machinery | - | 568.09 | 546.56 | 524.61 | 485.44 | 484.42 |
Construction In Progress | - | 92.91 | 78.2 | 67.67 | 69.34 | 58.26 |
Leasehold Improvements | - | 133.83 | 130.91 | 126.46 | 124.67 | 123.51 |